GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Nhu Co Ltd (SZSE:002001) » Definitions » Net-Net Working Capital

Zhejiang Nhu Co (SZSE:002001) Net-Net Working Capital : ¥-1.60 (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Nhu Co Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Zhejiang Nhu Co's Net-Net Working Capital for the quarter that ended in Jun. 2024 was ¥-1.60.

The industry rank for Zhejiang Nhu Co's Net-Net Working Capital or its related term are showing as below:

SZSE:002001's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.19
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Zhejiang Nhu Co Net-Net Working Capital Historical Data

The historical data trend for Zhejiang Nhu Co's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Nhu Co Net-Net Working Capital Chart

Zhejiang Nhu Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.50 -0.90 -0.65 -1.52 -1.82

Zhejiang Nhu Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.07 -1.89 -1.82 -1.58 -1.60

Competitive Comparison of Zhejiang Nhu Co's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Nhu Co's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Zhejiang Nhu Co's Price-to-Net-Net-Working-Capital falls into.



Zhejiang Nhu Co Net-Net Working Capital Calculation

Zhejiang Nhu Co's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net-Net Working Capital(A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(4716.417+0.75 * 2483.267+0.5 * 4318.879-14236.539
-0-115.046)/3090.91
=-1.82

Zhejiang Nhu Co's Net-Net Working Capital (NNWC) per share for the quarter that ended in Jun. 2024 is calculated as

Net-Net Working Capital(Q: Jun. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(4910.515+0.75 * 3246.277+0.5 * 4289.304-14311.273
-0-124.727)/3090.91
=-1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Zhejiang Nhu Co  (SZSE:002001) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Zhejiang Nhu Co Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Zhejiang Nhu Co's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Nhu Co Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Jiangbei Road, Yulin Street, Xinchang County, Zhejiang Province, Shaoxing, CHN, 312500
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer and Anti-bacterial with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3 and coenzyme Q10 and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
Executives
Hu Bai Fan Director
Shi Guan Qun Directors, Directors, and Executives
Hu Bai Shan Directors, executives
Cui Xin Rong Director
Chen Xue Cao Supervisors
Zhou Gui Yang Director
Qiu Jin Zhuo Supervisors
Wang Xue Wen Directors, executives
Wang Zheng Jiang Director
Ye Yue Heng Director
Dong Xiao Fang Supervisors
Liang Xiao Dong Supervisors
Zhang Xiao Bo Supervisors
Wang Xu Lin Supervisors
Ding Zhong Jun Director

Zhejiang Nhu Co Headlines

No Headlines